(OSCR) Oscar Health - Ratings and Ratios
Health Insurance, Tech Platform, Engagement Platform, Reinsurance Products
OSCR EPS (Earnings per Share)
OSCR Revenue
Description: OSCR Oscar Health
Oscar Health, Inc. is a pioneering healthcare technology company in the United States, revolutionizing the way health plans are offered to individuals, families, employees, and small group markets. By leveraging its cutting-edge +Oscar platform, the company empowers various stakeholders across the healthcare system. Additionally, its Campaign Builder platform serves as a sophisticated engagement and recommendation tool for providers and payors, while also offering reinsurance products to mitigate risk.
With its roots dating back to 2012 as Mulberry Health Inc., the company rebranded to Oscar Health, Inc. in January 2021, signaling a significant shift in its growth trajectory. Headquartered in New York, New York, Oscar Health has established itself as a key player in the Life & Health Insurance sub-industry, as classified by the GICS.
Analyzing the available
Forecasting Oscar Healths stock performance, we can anticipate a potential rebound if the company continues to innovate and expand its offerings. With its +Oscar platform and Campaign Builder, Oscar Health is poised to capitalize on the growing demand for healthcare technology solutions. If the stock price breaks above its 20-day SMA of $15.19, it may target the 52-week high of $23.27. Conversely, a decline below the 50-day SMA of $13.99 could signal a further downturn. Based on the available data, a reasonable price target for OSCR could be around $18.00 in the next 6-12 months, representing a potential upside of 22.5% from current levels.
Additional Sources for OSCR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
OSCR Stock Overview
Market Cap in USD | 5,460m |
Sector | Healthcare |
Industry | Healthcare Plans |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 2021-03-03 |
OSCR Stock Ratings
Growth Rating | -34.6 |
Fundamental | 58.5 |
Dividend Rating | 0.0 |
Rel. Strength | 7.4 |
Analysts | 3.29 of 5 |
Fair Price Momentum | 14.69 USD |
Fair Price DCF | 113.89 USD |
OSCR Dividends
Currently no dividends paidOSCR Growth Ratios
Growth Correlation 3m | 73.9% |
Growth Correlation 12m | -44.6% |
Growth Correlation 5y | 10.3% |
CAGR 5y | -16.25% |
CAGR/Max DD 5y | -0.17 |
Sharpe Ratio 12m | -1.18 |
Alpha | -5.60 |
Beta | 0.369 |
Volatility | 149.36% |
Current Volume | 30053k |
Average Volume 20d | 23665.7k |
Stop Loss | 14.8 (-8%) |
As of July 10, 2025, the stock is trading at USD 16.08 with a total of 30,052,994 shares traded.
Over the past week, the price has changed by -3.25%, over one month by +8.94%, over three months by +28.43% and over the past year by +2.10%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Oscar Health (NYSE:OSCR) is currently (July 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.53 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of OSCR is around 14.69 USD . This means that OSCR is currently overvalued and has a potential downside of -8.64%.
Oscar Health has received a consensus analysts rating of 3.29. Therefor, it is recommend to hold OSCR.
- Strong Buy: 2
- Buy: 1
- Hold: 2
- Sell: 1
- Strong Sell: 1
According to our own proprietary Forecast Model, OSCR Oscar Health will be worth about 16.3 in July 2026. The stock is currently trading at 16.08. This means that the stock has a potential upside of +1.12%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 17.5 | 8.8% |
Analysts Target Price | 19.4 | 20.8% |
ValueRay Target Price | 16.3 | 1.1% |